We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Professional black and white headshot of a smiling CEO in a suit jacket.
Credit: Dave Mullarkey.

Dave Mullarkey profile page

Chief Executive Officer

 at ClearNote Health

Dave Mullarkey serves as CEO of ClearNote Health, a company using epigenomic and genomic data to profile diseases and provide early detection of some of the deadliest types of cancer.


Areas of Expertise

Epigenetics
Genomics
Cancer Epigenetics

Got a Question for Dave Mullarkey?

Get in touch using the contact form linked here and we'll get back to you shortly.



Content Written By, Reviewed By, or Featuring Dave Mullarkey
Total: 1
Microscopic view of bone marrow cells used in epigenetic analysis for liquid biopsy applications.
Article

For Actionable Drug Information, Consider Dynamic Epigenetics Data

DNA sequencing alone misses many disease dynamics. Researchers are turning to epigenomic profiling, especially the biomarker 5hmC, to track active gene regulation through blood samples.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter